New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News For AAPL;JPM;RDSA;NVS;BKS;WDC;GD;VIA;VIAB;BLK;MPC From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
<< 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | all recent news | >>
November 18, 2014
08:01 EDTAAPLApple price target raised to $130 from $115 at Oppenheimer
Subscribe for More Information
07:16 EDTAAPLSamsung to produce APs for iPhones, iPads beginning in 2015, Korea Times reports
According to the Korea Times, sources say that Apple (AAPL) will outsource the bulk of its application processors manufacturing to Samsung (SSNLF) for iPhones and iPads starting in 2015. This agreement will cause Samsung to become a primary supplier of APs to Apple, moving Taiwan Semi (TSM) into second place. Reference Link
06:30 EDTMPCMarathon Petroleum coverage resumed with a Buy at Goldman
Target $127.
06:28 EDTAAPLNokia to launch Android tablet, FT reports
Subscribe for More Information
November 17, 2014
16:52 EDTNVSNovartis' LCZ696 could change course of heart failure for patients, study shows
New data on Novartis' investigational medicine, LCZ696, for patients with heart failure with reduced ejection fraction shows it has the potential to change the course of the disease for patients. In August, Novartis presented topline results from the landmark PARADIGM-HF study showing LCZ696 was superior to ACE inhibitor enalapril on key endpoints, including significantly reducing the risk of CV death or heart failure hospitalization. The new analyses being presented for the first time at the American Heart Association Scientific Sessions 2014, with a paper being simultaneously published in Circulation, show that versus enalapril, LCZ696 significantly: reduced the risk of dying suddenly by 20% in HFrEF patients 45% of CV deaths and 36% of all cause deaths are sudden; reduced first and subsequent HFrEF hospitalizations by 21% and 23% respectively; reduced hospitalizations for a cardiovascular reason or for any reason both by 16%; reduced the need for more intense treatment at home by 16%; reduced emergency room visits because of rapid symptom worsening by 30%.
16:00 EDTAAPLOptions Update; November 17, 2014
Subscribe for More Information
11:14 EDTAAPLApple price target raised to $120 from $115 at RBC Capital
RBC Capital earlier increased its price target on Apple as the firm estimates that the company's watch will generate $10B in revenue and 40c in EPs in the first 12 months after it's released. The firm increased its FY15 sales estimates for the company by $6.5B and raised its FY15 EPS estimate by 24c. It keeps an Outperform rating on the shares.
11:11 EDTRDSAHigh option volume stocks:
Subscribe for More Information
11:06 EDTNVSLeerink biotech analysts hold an analyst/industry conference call
Subscribe for More Information
10:06 EDTJPMSears Canada, JPMorgan Chase announce changes to credit card program
Subscribe for More Information
09:36 EDTAAPLActive equity options trading
Active equity options trading according to Track Data: AAPL PBR BHI GILD MU HD AMZN TSLA YHOO FB TWTR
06:18 EDTJPMJPMorgan reports October net credit losses 2.26% vs. 2.24% last month
Reports October delinquency rate 1.34% vs. 1.30% last month.
November 16, 2014
20:04 EDTAAPLApple: App Store adds UnionPay as payment option for customers in China
Subscribe for More Information
17:42 EDTJPMJPMorgan settles mineral rights suit in Texas, Bloomberg says
JPMorgan settled a lawsuit by Texas mineral-rights owners that accused the bank of negotiating "sweetheart deals" with oil company clients to cheat them out of $681M in compensation, says Bloomberg. Beneficiaries of the South Texas Syndicate Trust alleged that JPMorgan entered into favorable deals for its commercial banking clients on the trustís rights in the Eagle Ford, added Bloomberg. Reference Link
15:07 EDTNVSNovartis says arthritis drug secukinumab met primary endpoint
Subscribe for More Information
November 14, 2014
17:13 EDTAAPLAppaloosa gives quarterly update on stakes
NEW STAKES: NXP Semiconductors (NXPI), Lorillard (LO), Alibaba (BABA), and Shire (SHPG). INCREASED STAKES: Whirlpool (WHR), Priceline (PCLN), Delta (DAL), CBS (CBS), and General Motors (GM). DECREASED STAKES: American Airlines (AAL), Disney (DIS), Apple (AAPL), MGM Resorts (MGM), and Eastman Chemical (EMN). LIQUIDATED STAKES: Expedia (EXPE), AIG (AIG), Prudential (PRU), Celanese (CE), and ASML Holding (ASML).
16:01 EDTAAPLOptions Update; November 14, 2014
Subscribe for More Information
14:53 EDTNVSCVS Express Scripts implementing drug price controls, says Cleveland Research
Cleveland Research believes that CVS (CVS) and Express scripts are implementing rebates and price controls on drug. The firm expects the companies to increase their focus on controlling durg prices next year, and adds that they have already itnroduced prior authorization criteria for hepatitis drug. Publicly traded drug companies include AstraZeneca (AZN), Bristol-Myers (BMY), Eli Lilly (LLY), GlaxoSmithKline (GSK), Johnson & Johnson (JNJ), Merck (MRK), Novartis (NVS), Pfizer (PFE), Roche (RHHBY) and Sanofi (SNY). Makers of hepatits c drugs include AbbVie (ABBV) and Gilead (GILD),
10:49 EDTAAPLReport: iPhone 6 outselling iPhone 6 Plus 3-to-1 margin, Apple Insider says
Apple's iPhone 7 lineup is mostly driven by the 4.7-inch model, accounting for 68% of all iPhone sales, while the iPhone 6 Plus took between 23%-24%, reports Apple Insider. Citing a report from Consumer Intelligence Research Partners, the new iPhones represented 91% of total iPhone sales compared to the iPhone 5s and 5c accounting for 84% of total iPhone sales a year ago. Reference Link
10:03 EDTVIABHigh option volume stocks
Subscribe for More Information
<< 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use